MedPath

Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion

Not Applicable
Conditions
Spinal Fusion
Registration Number
NCT03692845
Lead Sponsor
Assiut University
Brief Summary

A study that compares between Open TLIF and Minimally invasive TLIF regarding patients' functional status(Oswestry Disability index)as a primary outcome measure.

Detailed Description

The first randomized controlled trial comparing minimally invasive TLIF and open TLIF.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Adults more than 18 years of age and less than 65 years of age..
  • Degenerative or isthmic spondylolithesis Grade 1,2 and 3.
  • Recurrent Symptomatic recurrent lumbar disc prolapsed with or without evident neural compression.
  • Single level pathology involving L2-3, L3-4, L4-5 and or L5-S1.
  • Symptoms not responding to conservative treatment for at least 3 months.
Exclusion Criteria
  • Previous spinal fusion or instrumentation.
  • Spinal tumours, infection and fractures.
  • Patients with severe osteoporosis
  • BMI more than 35.
  • Non-ambulant patients and patients with severe preoperative neurological affection (Cauda Equina Syndrome)
  • Patients not willing to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Oswestry Disability index(Arabic version) 1 month1 month

an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain.

Secondary Outcome Measures
NameTimeMethod
• Fusion rate as assessed by Bridwell fusion score.1 year

Grade I is defined as fusion with remodelling and trabeculae present; Grade II is an intact graft with incomplete remodelling and no lucency present; Grade III is an intact graft with potential lucency at the cranial or caudal end; Grade IV is absent fusion with collapse/resorption of the graft.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.